The pathogenetic role of impaired fatty acid trapping by adipocytes in generating the pleiotropic features of hyperapoB

Diabetologia

Volumn 40, Issue SUPPL. 2, 1997, Pages

  Sniderman, A D ^a,c   Cianflone, K ^a   Frayn, K ^b  

^a MCGILL UNIVERSITY   (Canada)

^b Oxford Lipid Metabolism Group   (United Kingdom)

^c ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; FATTY ACID; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADIPOCYTE; CONFERENCE PAPER; DYSLIPOPROTEINEMIA; FATTY ACID TRANSPORT; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN SECRETION; PRIORITY JOURNAL;

ADIPOCYTES; APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; BLOOD PROTEINS; COMPLEMENT C3A; FATTY ACIDS; HUMANS; HYPERLIPOPROTEINEMIAS; LIPOPROTEINS, LDL;

EID: 0030871946     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051435     Document Type: Conference Paper

References (26)

1. Sniderman AD, Shapiro S, Marpole DG, Skinner BF, Teng B, Kwiterovich PO (1980) Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low-density (B) lipoproteins]. Proc Natl Acad Sci USA 77(1):604-608
2. Lamarche B, Despres JP, Moorjani S, Cantin B, Dagenais GR, Lupien PJ (1995) Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results form the Quebec Cardiovascular Study). Am J Cardiol 75: 1189-1195
3. Teng B, Sniderman AD, Soutar AK, Thompson GR (1986) Metabolic basis of hyperapobetalipoproteinemia: turnover of apolipoprotein B in low-density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia. J Clin Invest 77(3):663-672
4. Teng B, Thompson GR, Sniderman AD, Forte TM, Krauss RM, Kwiterovich PO Jr (1983) Composition and distribution of low-density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia and familial hypercholesterolemia. Proc Natl Acad Sci USA 80(21):6662-6666
5. Goldberg IJ (1996) Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 37: 693-707
6. Frayn KN, Shadid S, Hamiani R et al. (1994) Regulation of fatty acid movement in human adipose tissue in the postabsorptive-to-postprandial transition. Am J Physiol 266: E306-E317
7. Baldo A, Sniderman AD, St-Luce S et al. (1993) The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest 92(3): 1543-1557
8. Cianflone K, Maslowska M, Sniderman AD (1995) The acylation stimulating protein-adipsin system. Symposium proceeding. Int J Obesity (19):S34-S38
9. Cianflone K, Maslowska M, Sniderman AD (1990) Impaired response of fibroblasts in patients with hyperapobetalipoproteinemia to acylation stimulating protein. J Clin Invest 85(3):722-730
10. Baldo A, Sniderman AD, Yasruel Z, Cianflone K (1995) The signal transduction pathway of acylation stimulating protein: involvement of protein kinase C. J Lipid Res (36):1415-1426
11. Yasruel Z, Cianflone K, Sniderman AD, Rosenbloom M, Walsh M, Rodriguez MA (1991) Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Lipids 26(7):495-499
12. Germinario R, Sniderman AD, Manuel S, Pratt S, Baldo A, Cianflone K (1993) Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation stimulating protein. Metabolism 40(5):574-580
13. Tao Y, Cianflone K, Sniderman AD, Colby-Germinario SP, Germinario RJ (1996) Acylation stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line. Biochim Biophys Acta 1344(3): 221-229
14. Cianflone K, Roncari DAK, Maslowska M, Baldo A, Forden J, Sniderman AD (1994) The adipsin-acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry 33(14):9489-9495
15. Cianflone K, Maslowska M (1995) Differentiation induced production of ASP in human adipocytes. Eur J Clin Invest 25: 817-825
16. Cianflone K, Vu H, Walsh M, Baldo A, Sniderman AD (1989) Metabolic response of acylation stimulating protein to an oral fat load. J Lipid Res 30(11):1727-1733
17. Maslowska M, Scantlebury T, Germinario R, Cianflone K (1993) Acute in vitro production of ASP in differentiated human adipocytes. J Lipid Res 34(2):219-228
18. Bengtsson G, Olivecrona T (1980) Lipoprotein lipase. Mechanism of product inhibition. Eur J Biochem 106: 557-562
19. Saxena U, Witte LD, Goldberg IJ (1989) Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids. J Biol Chem 264(8):4349-4355
20. Genest J, Sniderman AD, Cianflone K et al. (1986) Hyperapobetalipoproteinemia: plasma lipoprotein responses to oral fat load. Arteriosclerosis 6(3):297-304
21. Sniderman AD, Brown BG, Stewart FF, Cianflone K (1992) From familial combined hyperlipidemia to hyperapoB: unravelling overproduction of hepatic apoB lipoproteins. Current Opinion in Lipidology 3(2):137-142
22. Sniderman AD, Cianflone K (1993) Substrate delivery as a determinant of hepatic apoB secretion. Arterio Thromb 13(5):629-636
23. Sniderman AD, Thomas D, Marpole DG, Teng B (1978) Low-density lipoprotein: a metabolic pathway for return of cholesterol to the splanchnic bed. J Clin Invest 61: 867-873
24. Frayn KN, Williams CM, Arner P (1996) Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic disease? Clinical Science 90: 243-253
25. Maslowska MH, Sniderman AD, MacLean LD, Cianflone K (1993) Regional differences in triacylglycerol synthesis in adipose tissue. J Lipid Res 34(2):219-228
26. Edens NK, Fired SK, Kral JG, Hirsch J, Leibel RL (1993) In vitro lipid synthesis in human adipose from three abdominal sites. Am J Physiol 265(28):E374-E379